| 2025/09 - 九個月 人民幣(K¥) | 與去年末期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 6,353 | 0.00% | 6,353 | 6,500 | 0 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 902,491 | -5.59% | 955,906 | 849,035 | 461,656 | 248,517 |
| 在建工程 | 0 | -100.00% | 3,041 | 112,254 | 523,346 | 238,714 |
| 無形資產 | 15,889 | -9.28% | 17,514 | 15,376 | 17,233 | 18,766 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 596,717 | 7.18% | 556,768 | 569,205 | 563,729 | 569,457 |
| 1,521,450 | -1.18% | 1,539,581 | 1,552,371 | 1,565,965 | 1,075,454 | |
流動資產 | ||||||
| 貨幣資金 | 943,133 | -5.81% | 1,001,327 | 1,039,366 | 651,463 | 926,879 |
| 應收賬款 | 1,315,557 | 1.28% | 1,298,879 | 1,410,519 | 1,287,074 | 837,177 |
| 存貨 | 147,383 | -16.68% | 176,882 | 173,536 | 153,646 | 105,493 |
| 其他流動資產 | 9,974 | -8.60% | 10,913 | 33,476 | 52,918 | 73,039 |
| 2,416,047 | -2.89% | 2,488,001 | 2,656,897 | 2,145,100 | 1,942,587 | |
流動負債 | ||||||
| 短期借款 | 149,883 | -19.80% | 186,889 | 190,914 | 109,296 | 0 |
| 應付票據 | 0 | -100.00% | 938 | 4,000 | 17,804 | 0 |
| 應付帳款 | 1,977 | -60.19% | 4,966 | 3,129 | 16,338 | 6,058 |
| 其他流動負債 | 261,019 | -30.13% | 373,577 | 483,682 | 468,270 | 332,879 |
| 412,879 | -27.10% | 566,369 | 681,725 | 611,708 | 338,937 | |
| 流動資產淨值 | 2,003,167 | 4.24% | 1,921,632 | 1,975,173 | 1,533,392 | 1,603,650 |
| 資產總額減流動負債 | 3,524,617 | 1.83% | 3,461,213 | 3,527,543 | 3,099,357 | 2,679,104 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 0 | 15,748 | 0 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 17,945 | 30.94% | 13,705 | 13,492 | 7,941 | 8,804 |
| 17,945 | 30.94% | 13,705 | 13,492 | 23,689 | 8,804 | |
總權益 | ||||||
| 實收股本 | 129,947 | -2.26% | 132,947 | 134,650 | 134,650 | 90,000 |
| 儲備項目 | 3,376,726 | 1.88% | 3,314,562 | 3,379,401 | 2,941,018 | 2,580,301 |
| 股東權益 | 3,506,673 | 1.72% | 3,447,509 | 3,514,052 | 3,075,668 | 2,670,301 |
| 非控股權益 | 0 | -- | 0 | 0 | 0 | 0 |
300841 康華生物
按盤價 
76.700 -0.270 (-0.35%)
76.700 -0.270 (-0.35%)| 備註： | 報價延遲最少15分鐘，資料更新時間為 04/11/2025 12:34 |
